Eve & Co Receives Expanded Health Canada Licences
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) — Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the […]
Abattis to Display Products and Services at O’Cannabiz Conference on December 10-11th, 2018
VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased […]
Allscripts to sell its interests in Netsmart
CHICAGO, Dec. 10, 2018 (GLOBE NEWSWIRE) — Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, today announced that […]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SANTA BARBARA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today […]
Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin Immunoassay
Thermo Fisher Scientific and Achaogen jointly develop new assay to enable Therapeutic Drug Management SOUTH SAN FRANCISCO, Calif., Dec. 10, […]
TSX News -
TECSYS Receives a 2018 Supply & Demand Chain Executive Green Supply Chain Award
MONTREAL, Dec. 10, 2018 (GLOBE NEWSWIRE) — Supply & Demand Chain Executive, the executive’s user manual for successful supply and […]
VMware Receives Highest Product Scores in Two of Three Use Cases in Gartner’s Critical Capabilities for WAN Edge Infrastructure
VMware is the highest ranked vendor for both Midsize Enterprise/Regional and Large Global WAN use cases PALO ALTO, Calif., Dec. […]
Pfenex Submits New Drug Application to U.S. FDA Seeking Approval of PF708 for the Treatment of Osteoporosis
Submitted as a 505(b)(2) NDA with an Expected Ten-Month Review SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) — Pfenex Inc. […]
Bonanza Creek Announces New $350 Million Borrowing Base
DENVER, Dec. 10, 2018 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (NYSE: BCEI) (the “Company”) announced today that the Company […]
Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki, Finland as Coordinating Principal Investigator for Phase 3 Clinical Trial of AD04 for the Treatment of Alcohol Use Disorder
CHARLOTTESVILLE, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com a clinical-stage biopharmaceutical company focused […]
